DIAPREL MR

Modified-release tablet, 60mg
RxActive license

Active substance (INN)

gliclazide

Pharmaceutical form

Pharmaceutical formModified-release tablet
Strength60mg
PackagingUkupno 30 tableta sa modifikovanim oslobađanjem u blisteru (2x15) u kartonskoj kutiji
ManufacturerLes Laboratoires Servier Industrie, France
Therapeutic groupAlimentary tract and metabolism (A10BB09)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateFebruary 24, 2025

Analogs in Montenegro

3

Other medicines with the same active substance

DIAPREL MRRx
Modified-release tablet, 60mgLes Laboratoires Servier Industrie
GLICLADA®Rx
Prolonged-release tablet, 60mgKrka d.d.
GLIORALRx
Tablet, 80mgGalenika a.d. Beograd
Source: CInMED register